Is there a link between mean platelet volume and thrombotic events in antiphospholipid syndrome?

Platelets

Volumn 25, Issue 5, 2014, Pages 343-347

  Korkmaz, Serdal ^a   Uslu, Ali Ugur ^a   Sahin, Safak ^b   Senel, Soner ^c   Sencan, Mehmet ^a  

^a CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b GAZIOSMANPASA UNIVERSITY   (Turkey)

^c ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Antiphospholipid syndrome; Mean platelet volume; Thrombosis

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN; HEPARIN; HYDROXYCHLOROQUINE; PREDNISOLONE; WARFARIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; CAVERNOUS SINUS THROMBOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; LEUKOCYTE; LEUKOCYTE COUNT; LUNG EMBOLISM; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPLENIC VEIN; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; THROMBOSIS; VEIN THROMBOSIS; BLOOD; MIDDLE AGED; PROCEDURES; YOUNG ADULT;

ADULT; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; PLATELET ACTIVATION; THROMBOSIS; YOUNG ADULT;

EID: 84903939421     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2013.824563     Document Type: Article

References (38)

1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, de Groot PG, Koike T, Meroni PL, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4(2): 295-306.
2. Ozturk MA, Haznedaroglu IC, Turgut M, Goker H. Current debates in antiphospholipid syndrome: The acquired antibody-mediated thrombophilia. Clin Appl Thromb Hemost 2004;10: 89-126. (Pubitemid 38490079)
3. Pierangeli SS, Chen PP, Raschi E, Scurati S, Grossi C, Borghi MO, Palomo I, Harris EN, Meroni PL. Antiphospholipid antibodies and the antiphospholipid syndrome: Pathogenic mechanisms. Semin Thromb Hemost 2008;34: 236-250.
4. Krone KA, Allen KL, Mc Crae KR. Impaired fibrinolysis in the antiphospholipid syndrome. Curr Rheumatol Rep 2010;12(1): 53-57.
5. Wagner DD. New links between inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2005;24: 1321-1324. (Pubitemid 40923346)
6. Gasparyan AY, Ayvazyan L, Pretorius E, Kitas GD. Platelets in rheumatic diseases: Friend or foe? Curr Pharm Des 2013;Apr 2 [Epub ahead of print].
7. Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Douglas KM, Kitas GD. Platelet function in rheumatoid arthritis: Arthritic and cardiovascular implications. Rheumatol Int 2011;31: 153-164.
8. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: A link between thrombosis and inflammation? Curr Pharm Des 2011;17: 47-58.
9. Gasparyan AY, Sandoo A, Stavropoulos-Kalinoglou A, Kitas GD. Mean platelet volume in patients with rheumatoid arthritis: The effect of anti-TNF-a therapy. Rheumatol Int 2010;30: 1125-1129.
10. Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 2004;35: 1688-1691. (Pubitemid 38823648)
11. Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40(9):1725.
12. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, et al Euro-Phospholipid Project Group. Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 2002;46: 1019-1027. (Pubitemid 34303815)
13. Rand JH, Wu XX, Quinn AS, Taatjes DJ. Resistance to annexin A5 anticoagulant activity: A thrombogenic mechanism for the antiphospholipid syndrome. Lupus 2008;17: 922-930.
14. Lim W. Antiphospholipid antibody syndrome. Hematology Am Soc Hematol Educ Program 2009;233-239.
15. Meroni PL, Borghi MO, Raschi E, Tedesco F. Pathogenesis of antiphospholipid syndrome: Understanding the antibodies. Nat Rev Rheumatol 2011;7(6): 330-339.
16. Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 2001;88(8): 756-762. (Pubitemid 32429970)
17. Belizna C, Lartigue A, Favre J, Gilbert D, Tron F, Levesque H, Thuillez C, Richard V. Antiphospholipid antibodies induce vascular functional changes in mice: A mechanism of vascular lesions in antiphospholipid syndrome? Lupus 2008;17(3): 185-194. (Pubitemid 351588940)
18. Ramesh S, Morrell CN, Tarango C, Thomas GD, Yuhanna IS, Girardi G, Herz J, Urbanus RT, de Groot PG, Thorpe PE, et al. Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via b2GPI and apoER2. J Clin Invest 2011;121(1): 120-131.
19. Giannakopoulos B, Passam F, Rahgozar S, Krillis SA. Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 2007;109: 422-430. (Pubitemid 46105935)
20. Levine JS, Branch W, Rauch J. The antiphospholipid syndrome. N Eng J Med 2002;346: 752-763. (Pubitemid 34983997)
21. Davis WD, Brey RL. Antiphospholipid antibodies and complement activation in patients with cerebral ischemia. Clin Exp Immunol 1992;10: 445-460.
22. Shinzato MM, Bueno C, Trindade-Viana VS, Borba EF, Goncalves CR, Bonfa E. Complement fixing activity of anticardiolipin antibodies in patients with and without thrombosis. Lupus 2005; 14: 953-958. (Pubitemid 43088269)
23. De Jong A, Siboh V, Robbins D. Antiphospholipid antibodies and platelets. Curr Rheum Rep 2000;2: 238-245.
24. Ardoin SP, Shanahan JC, Pisetsky DS. The role of microparticles in inflammation and thrombosis. Scand J Immunol 2007;66: 159-165. (Pubitemid 47063209)
25. Palatinus A, Adams M. Thrombosis in systemic lupus erythematosus. Semin Thromb Hemost 2009;35: 621-629.
26. Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, Massarotti EM, Remold-O'Donnell E, Farndale RW, Ware J, et al. Platelets amplify inflammation in arthritis via collagendependent microparticle production. Science 2010;327: 580-583.
27. Thompson CB. From precursor to product: How do megakaryocytes produce platelets? Prog Clin Biol Res 1986;215: 361-371.
28. Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: -Is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003;9: 177-190. (Pubitemid 37070125)
29. Chu H, Chen WL, Huang CC, Chang HY, Kuo HY, Gau CM, Chang YC, Shen YS. Diagnostic performance of mean platelet volume for patients with acute coronary syndrome visiting an emergency department with acute chest pain: The Chinese scenario. Emerg Med J 2011;28(7): 569-574.
30. Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002;117: 399-404. (Pubitemid 34451156)
31. Mayda-Domaç F, Misirli H, Yilmaz M. Prognostic role of mean platelet volume and platelet count in ischemic and hemorrhagic stroke. J Stroke Cerebrovasc Dis 2010;19: 66-72.
32. Paramo JA, Rocha E. Deep vein thrombosis and related platelet changes after total hip replacement. Haemostasis 1985;15: 389-394. (Pubitemid 16206088)
33. Braekkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Størmer J, Hansen JB. Mean platelet volume is a risk factor for venous thromboembolism: The Tromsø Study, Tromsø, Norway. J Thromb Haemost 2010;8: 157-162.
34. Kostrubiec M, Labyk A, Pedowska-Wloszek J, Hrynkiewicz- Szymańska A, Pacho S, Jankowski K, Lichodziejewska B, Pruszczyk P. Mean platelet volume predicts early death in acute pulmonary embolism. Heart 2010;96: 460-465.
35. Acikgoz N, Karincaoglu Y, Ermis N, Yagmur J, Atas H, Kurtoglu E, Cansel M, Barutcu I, Pekdemir H, Ozdemir R. Increased mean platelet volume in Behçet's disease with thrombotic tendency. Tohoku J Exp Med 2010;221: 119-123.
36. Rupa-Matysek J. No Correlation between mean platelet volume and the risk of recurrent venous or arterial thrombosis in patients with antiphospholipid syndrome. In 58th Annual Meeting of the SSC of the ISTH, Liverpool, U.K. 2012 June 27-30, ePoster presentation. Available from: http://www.multiwebcast.com/ isth/2012/ssc/21102/.
37. Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk MA, Kiraz S, Ertenli I, Calguneri M. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 2008;75: 291-294.
38. Hamid C, Norgate K, Cruz DPD, Kamashta MA, Arno M, Pearson JD, Frampton G, Murphy JJ. Anti-beta2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome. Ann Rheum Dis 2007;66: 1000-1007. (Pubitemid 47122310)